Durvadi tail effect in Wound healing

Comprehensive Single Arm Trial in The Management of Dustha Vrana (Wound) WSR to Culture and Sensitivity Test - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093622

Enrollment

Registered

2025-08-25

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T148- Other injury of unspecified body region

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with classical sign and symptom of DushtaVrana for example diabetic wound will be included in the trial Patient who will give written consent

Exclusion criteria

Exclusion criteria: Patient suffering from any malignancy. Patient who is not eligible for Shodhan of Vrana according to Sushrut Samhita. Patient suffering from tuberculosis. Patient suffering from HIV & Hepatitis B. Patient suffering from any major systemic disorder.

Design outcomes

Primary

Measure	Time frame
Generation of scientific evidence on the efficacy of Durvadi Taila in wound management in context of antimicrobial properties.Timepoint: 30 days	—

Secondary

Measure	Time frame
Secondary outcomes will provide a more comprehensive and indepth understanding of the potential benefits, safety, and broader implications in clinical practice of Durvadi Taila and contributing to evidence-based decision-making for wound managementTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDR PRINCE MEENA

POSTGRADUATE INSTITUTE OF AYURVEDA

sanjayphyayu@gmail.com9414410383

Outcome results